Merck & Co Inc (NYSE:MRK)
| 72.97 BATS BZX Real-Time Price As of 12:52pm ET |  +0.35 / +0.48%Today’s Change | 65.25 Today|||52-Week Range 87.80 | -10.79% Year-to-Date |
Latest MRK News | Press Releases
Today’s Trading
| Previous close | 72.62 |
| Today’s open | 73.21 |
| Day’s range | 72.95 - 73.39 |
| Volume | 4,439,157 |
| Average volume (3 months) | 9,538,384 |
| Market cap | $183.8B |
Data as of 12:52pm ET, 03/01/2021
Growth & Valuation
| Earnings growth (last year) | -27.21% |
| Earnings growth (this year) | +9.09% |
| Earnings growth (next 5 years) | +8.00% |
| Revenue growth (last year) | +3.06% |
| P/E ratio | 16.1 |
| Price/Sales | 4.33 |
| Price/Book | 7.26 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | +0.30 | +0.91% |
| ABBVAbbVie | +1.08 | +1.00% |
| NVSNovartis | +1.17 | +1.36% |
| LLYEli Lilly and Co | +1.87 | +0.91% |
Data as of 12:52pm ET, 03/01/2021
Financials
| Next reporting date | April 29, 2021 |
| EPS forecast (this quarter) | $1.62 |
| Annual revenue (last year) | $48.0B |
| Annual profit (last year) | $7.1B |
| Net profit margin | 14.72% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
